Lisanti Capital Growth
Lisanti Capital Growth reported 95 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CORT (2.8%), HNGE (2.6%) and KNSA (2.6%). Compared with Q2 2026, the fund opened new positions in CDNA, GKOS and ELF, added to KNSA, MGNI and FIVN, trimmed CORT, HNGE and HTFL and sold out of BTSG, ALGM and MIRM.
Latest filing: what Lisanti Capital Growth did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() CORT Corcept Therapeutics Inc | $10.3M | 2.8% | 89K | −2,260 (−2%) | 6 of 8 | |
| 2 | ![]() HNGE Hinge Health Inc | $9.9M | 2.6% | 102K | −37K (−27%) | 6 of 8 | |
| 3 | ![]() KNSA Kiniksa Pharmaceuticals Intl | $9.6M | 2.6% | 129K | +42K (+48%) | 3 of 8 | |
| 4 | ![]() MGNI Magnite Inc | $9.1M | 2.5% | 361K | +72K (+25%) | 7 of 8 | |
| 5 | ![]() CDNA Caredx Inc | $8.5M | 2.3% | 130K | New position | 1 of 8 | |
| 6 | ![]() HTFL Heartflow Inc | $7.7M | 2.1% | 155K | −34K (−18%) | 5 of 8 | |
| 7 | ![]() ZETA Zeta Global Holdings Corp | $7.7M | 2.1% | 245K | −107K (−30%) | 8 of 8 | |
| 8 | ![]() GKOS Glaukos Corp | $7.2M | 1.9% | 44K | New position | 4 of 8 | |
| 9 | ![]() FIVN FIVE9 Inc | $6.8M | 1.8% | 201K | +7,430 (+4%) | 2 of 8 | |
| 10 | ![]() ELF E L F Beauty Inc | $6.5M | 1.7% | 64K | New position | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() BTSG Brightspring Health Svcs Inc | $10.8M | 155K |
![]() ALGM Allegro Microsystems Inc | $7.5M | 108K |
![]() MIRM Mirum Pharmaceuticals Inc | $7.4M | 63K |
![]() CRS Carpenter Technology Corp | $7.2M | 12K |
![]() DY Dycom Inds Inc | $7.2M | 14K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 5, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Lisanti Capital Growth 13F FAQ
What does Lisanti Capital Growth own?
Lisanti Capital Growth reported 95 stocks worth $373M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CORT (2.8%), HNGE (2.6%) and KNSA (2.6%). The table above lists every position in the filing (the top 10 without an account).
What did Lisanti Capital Growth buy and sell in Q3 2026?
Compared with Q2 2026: 52 new positions, 13 added to, 29 trimmed and 66 sold out. New positions include CDNA, GKOS and ELF. It sold all of BTSG, ALGM and MIRM.
When will Lisanti Capital Growth file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Lisanti Capital Growth's portfolio worth?
The Q3 2026 filing reports $373M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
From SEC Form 13F filings ยท Not investment advice






















